![VJHemOnc Podcast](https://pbcdn1.podbean.com/imglogo/image-logo/8189927/VJH_Thumbnail_1400b48w2.jpg)
58.3K
Downloads
272
Episodes
The Video Journal of Hematology and Hematological Oncology (VJHemOnc) podcast covers the latest hematological oncology and hematology news from international experts – from leukemias, lymphomas, MDS and MPNs, to sickle cell, aplastic anemia and rare diseases. Made for healthcare professionals and researchers, we are a global, independent, open-access platform. Listen to the latest news, including cutting-edge trial updates, controversies and opinion. If you enjoy the podcast, please leave us a rating and review! For more news visit www.vjhemonc.com
Episodes
![CAR-T and lymphoma treatment in the UK](https://pbcdn1.podbean.com/imglogo/image-logo/8189927/VJH_Thumbnail_1400b48w2_300x300.jpg)
Friday May 27, 2022
CAR-T and lymphoma treatment in the UK
Friday May 27, 2022
Friday May 27, 2022
Lymphoma treatment has seen many recent advances, with CAR-T therapy being a game changer for patients. Several clinical trials investigating the safety and efficacy of CAR-T products are ongoing, and many experts in the field are eager to see how the availability of CAR-T products will influence the treatment landscape. Of course, access to novel therapies varies in different regions, and while there are many approvals going through NICE, there are still questions that remain regarding lymphoma treatment in the UK.
In this exclusive podcast, Robin Sanderson, BSc, MBChB, MRCP, FRCPath, PhD, of King's College Hospital NHS Foundation Trust, London, UK, and Tobias Menne, MD, PhD, FRCPath, of the Newcastle upon Tyne NHS Foundation Trust, Newcastle, UK, discuss lymphoma treatment in the UK, drawing focus on CAR-T therapy, including the management toxicities, treating transplant-ineligible patients, and more.
Comments (0)
To leave or reply to comments, please download free Podbean or
No Comments
To leave or reply to comments,
please download free Podbean App.